The influence of co-morbidities on prescribing pharmacotherapy for insomnia: evidence from US national outpatient data 1995–2004

References

• Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. Sleep 1999; 22: 347–353
   PubMed Web of Science ®Google Scholar
• Smith MT, Neubauer DN. Cognitive behavior therapy for chronic insomnia. Clinical Cornerstone 2003; 5: 28–40
   PubMedGoogle Scholar
• Roth T, Roehrs T. Insomnia: epidemiology, characteristics, and consequences. Clinical Cornerstone 2003; 5: 5–15
   PubMedGoogle Scholar
• Mahendran R, Subramaniam M, Chan H. Psychiatric morbidity in patients referred to an insomnia clinic. Singapore Medical Journal 2007; 48: 163–165
   PubMedGoogle Scholar
• Becker PM. Insomnia: prevalence, impact, pathogenesis, differential diagnosis, and evaluation. Psychiatric Clinics of North America 2006; 29: 855–870
   PubMed Web of Science ®Google Scholar
• Stewart R, Besset A, Bebbington P, et al. Insomnia comorbidity and impact and hypnotic use by age group in a national survey population aged 16 to 74 years. Sleep 2006; 29: 1391–1397
   PubMed Web of Science ®Google Scholar
• Chilcott LA, Shapiro CM. The socioeconomic impact of insomnia. An overview. PharmacoEconomics 1996; 10: 1–14
   PubMed Web of Science ®Google Scholar
• Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. American Journal of Psychiatry 1994; 151: 1172–1180
   PubMed Web of Science ®Google Scholar
• Lippmann S, Mazour I, Shahab H. Insomnia: therapeutic approach. Southern Medical Journal. 2001; 94: 866–873
   Google Scholar
• Benca RM. Diagnosis and treatment of chronic insomnia: a review. Psychiatric Services (Washington, D.C.) 2005; 56: 332–343
   PubMed Web of Science ®Google Scholar
• Fraser AD. Use and abuse of the benzodiazepines. Therapeutic Drug Monitoring 1998; 20: 481–489
   Google Scholar
• Schweizer E, Rickels K. Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta psychiatrica Scandinavica. Supplementum 1998; 393: 95–101
   PubMedGoogle Scholar
• Longo L, Parran Jr T, Johnson B, et al. Addiction: part II. Identification and management of the drug-seeking patient. American Family Physician 2000; 61: 2401–2408
   PubMed Web of Science ®Google Scholar
• Erman MK. Influence of pharmacokinetic profiles on safety and efficacy of hypnotic medications. Journal of Clinical Psychiatry 2006; 67: 9–12
   Google Scholar
• Lader M. Zopiclone: is there any dependence and abuse potential?. Journal of Neurology 1997; 244((4 Suppl 1)): S18–S22
   Google Scholar
• Rush CR. Behavioral pharmacology of zolpidem relative to benzodiazepines: a review. Pharmacology, Biochemistry, and Behavior 1998; 61: 253–269
   PubMed Web of Science ®Google Scholar
• Darcourt G, Pringuey D, Salliere D, et al. The safety and tolerability of zolpidem—an update. Journal of Psychopharmacology 1999; 13: 81–93
   PubMed Web of Science ®Google Scholar
• Wagner J, Wagner ML. Non-benzodiazepines for the treatment of insomnia. Sleep Medicine Reviews 2000; 4: 551–581
   PubMed Web of Science ®Google Scholar
• Hajak G, Muller WE, Wittchen HU, et al. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 2003; 98: 1371–1378
   PubMed Web of Science ®Google Scholar
• Roth T, Jaeger S, Jin R, et al. Sleep problems, comorbid mental disorders, and role functioning in the national comorbidity survey replication. Biological Psychiatry 2006; 60: 1364–1371
   PubMed Web of Science ®Google Scholar
• Ohayon M, Roth T. Place of chronic insomnia in the course of depressive and anxiety disorders. Journal of Psychiatric Research 2003; 37: 9–15
   PubMed Web of Science ®Google Scholar
• Breslau N, Roth T, Rosenthal L, et al. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biological Psychiatry 1996; 39: 411–418
   PubMed Web of Science ®Google Scholar
• Livingston G, Blizard B, Mann A. Does sleep disturbance predict depression in elderly people? A study in inner London. British Journal of General Practice 1993; 43: 445–448
   PubMed Web of Science ®Google Scholar
• Riemann D, Voderholzer U. Primary insomnia: a risk factor to develop depression?. Journal of Affective Disorders 2003; 76: 255–259
   PubMed Web of Science ®Google Scholar
• Gottlieb DJ, Redline S, Nieto FJ, et al. Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep 2006; 29: 1009–1014
   PubMed Web of Science ®Google Scholar
• National Center for Health Statistics. Ambulatory health care data. NAMCS description. Available at: http://www.cdc.gov/nchs/about/major/ahcd/namcsdes.htm [accessed 16 February 2007]
   Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 1987; 40: 373–383
   PubMedGoogle Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology 1992; 45: 613–619
   PubMed Web of Science ®Google Scholar
• Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. Journal of Clinical Epidemiology 1993; 46: 1075–1079;; discussion 1081–1090.
   PubMed Web of Science ®Google Scholar
• Quan H, Parsons GA, Ghali WA. Validity of information on comorbidity derived from ICD-9-CM administrative data. Medical Care 2003; 40: 675–685
   Google Scholar
• Taylor JR, Vazquez CM, Campbell KM. Pharmacologic management of chronic insomnia. Southern Medical Journal 2006; 99: 1373–1377
   PubMed Web of Science ®Google Scholar
• National Sleep Foundation. Summary of findings. 2005 Sleep in America Poll. Available at: http://www.sleepfoundation.org/site/c.huIXKjM0IxF/b.2419039/k.14E4/2005_Sleep_in_America_Poll.htm [accessed 21 August 2007]
   Google Scholar
• Rasu RS, Shenolikar RA, Nahata MC, et al. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996–2001. Clinical Therapeutics 2005; 27: 1970–1979
   PubMed Web of Science ®Google Scholar
• Balkrishnan R, Rasu RS, Rajagopalan R. Physician and patient determinants of pharmacologic treatment of sleep difficulties in outpatient settings in the United States. Sleep 2005; 28: 715–719
   PubMed Web of Science ®Google Scholar
• Walsh JK. Drugs used to treat insomnia in 2002: regulatory-based rather than evidence-based medicine. Sleep 2004; 27: 1441–1442
   PubMed Web of Science ®Google Scholar
• Balkrishnan R, Cook JM, Shaffer MP, et al. Analysis of factors associated with prescription of a potentially inappropriate combination dermatological medication among US outpatient physicians. Pharmacoepidemiology and Drug Safety 2004; 13: 133–138
   Google Scholar
• Nadler E, Eckert B, Neumann PJ. Do oncologists believe new cancer drugs offer good value?. Oncologist 2006; 11: 90–95
   PubMed Web of Science ®Google Scholar
• Schneier FR. Social anxiety disorder. British Medical Journal 2003; 327: 515–516
   PubMed Web of Science ®Google Scholar